查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941419

傳染性呼吸道疾病診斷市場規模、佔有率和趨勢分析報告：按產品、應用、技術、最終用途、地區和細分市場預測，2026-2033年

Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis By Product, By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

傳染性呼吸道疾病診斷市場概述

全球傳染性呼吸道疾病診斷市場預計到 2025 年價值 125.6 億美元，預計到 2033 年將達到 157 億美元。

預計從 2026 年到 2033 年，該市場將以 2.90% 的複合年成長率成長。推動市場成長的幾個關鍵因素包括結核病和肺炎等疾病的增加、診斷技術的進步以及主要企業之間日益增多的合作與夥伴關係。

例如，2023年2月，賽默飛世爾科技（Thermo Fisher Scientific）和MyLab Discovery Solutions宣佈建立合作夥伴關係，共同開發和分銷用於感染疾病的診斷檢測套組，包括耐多藥結核病、乙型肝炎病毒、C型肝炎病毒、愛滋病毒以及基因分析（HLA B27），業務遍及印度。此次合作結合了賽默飛世爾的全球專業知識和MyLab的在地化生產能力，旨在擴大高品質偵測解決方案的覆蓋範圍。

增加結核病診斷計畫的資金投入對於對抗這一全球性疾病至關重要。目前用於預防、診斷和治療的資金不足以滿足需求，阻礙了降低發病率和死亡率的進展。例如，儘管到2027年每年計劃投入220億美元，另有50億美元用於研究，但僅有58億美元被分配給結核病防治服務——遠低於實現全球目標所需的金額。此外，世界衛生組織強調需要持續增加資金投入才能有效消除結核病。為此，美國政府已大幅增加結核病防治資金，從2013年的2.33億美元增加到2023年的4.06億美元。篩檢和預防性治療的投資已證明具有顯著的健康和經濟效益，每投入1美元，即可產生高達39美元的投資回報。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 傳染性呼吸道疾病診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 傳染性呼吸道疾病診斷市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析

第4章 傳染性呼吸道疾病診斷市場：依產品分類的估算與趨勢分析

  • 傳染性呼吸道疾病診斷市場：依產品分類的差異分析
  • 傳染性呼吸道疾病診斷市場：產品展望
  • 市場規模、預測與趨勢分析（2021-2033）
  • 裝置
  • 試劑
  • 服務

第5章感染疾病和呼吸系統疾病診斷市場：按技術分類的估計和趨勢分析

  • 傳染性呼吸道疾病診斷市場：依技術分類的差異分析
  • 傳染性呼吸道疾病診斷市場：技術展望
  • 市場規模、預測與趨勢分析（2021-2033）
  • 免疫檢測
  • 分子診斷
  • 微生物學
  • 快速/照護現場
  • 其他

第6章 傳染性呼吸道疾病診斷市場：按應用分類的估算與趨勢分析

  • 傳染性呼吸道疾病診斷市場：按應用分類的差異分析
  • 傳染性呼吸道疾病診斷市場：按應用領域分類的展望
  • 市場規模、預測與趨勢分析（2021-2033）
  • COVID-19
  • 流感
  • 呼吸道融合病毒（RSV）
  • 結核
  • 非結核分枝桿菌檢測
  • 細菌性肺炎檢測
  • 其他

7. 傳染性呼吸道疾病診斷市場：依最終用途分類的估算與趨勢分析

  • 傳染性呼吸道疾病診斷市場：依最終用途分類的差異分析
  • 傳染性呼吸道疾病診斷市場：依最終用途分類的視角
  • 市場規模、預測與趨勢分析（2021-2033）
  • 醫院
  • 診斷檢查室
  • 研究所
  • 診所

第8章 傳染性呼吸道疾病診斷市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 市場參與企業分類
  • 主要市場參與企業的最新趨勢和影響分析
  • 企業市場占有率分析（2025）
  • 主要企業簡介
    • ABBOTT
    • F. Hoffmann-La Roche Ltd
    • BD
    • KONINKLIJKE PHILIPS NV
    • BIOMERIEUX SA
    • BIO-RAD LABORATORIES, INC.
    • QUIDEL CORPORATION
    • CEPHEID
    • QIAGEN
    • SIEMENS HEALTHCARE GMBH
    • Seegene Inc.
    • EliTechGroup（Bruker Corporation）
    • CERTEST BIOTEC
    • Thermo Fisher Scientific, Inc.
Product Code: GVR-4-68039-976-4

Infectious Respiratory Disease Diagnostics Market Summary

The global infectious respiratory disease diagnostics market size was estimated at USD 12.56 billion in 2025 and is projected to reach USD 15.70 billion by 2033, growing at a CAGR of 2.90% from 2026 to 2033. The market is being driven by several key factors, including the growing prevalence of diseases like tuberculosis and pneumonia, advancements in diagnostic technologies, and increased partnerships and collaborations between major players.

For instance, in February 2023, Thermo Fisher Scientific and Mylab Discovery Solutions announced a partnership to develop and distribute diagnostic test kits for infectious diseases such as multi-drug-resistant tuberculosis, hepatitis B virus, hepatitis C virus, HIV, and genetic analysis (HLA B27) in India. The collaboration aims to combine Thermo Fisher's global expertise with Mylab's local manufacturing capabilities to expand access to high-quality testing solutions.

The increasing funding for TB diagnosis programs is crucial in the fight against this global disease. The current funding for prevention, diagnosis, and treatment is insufficient to meet the demand, hindering progress in reducing incidence & mortality rates. For instance, an annual investment of USD 22 billion by 2027 was set, with an additional USD 5 billion for research, and only USD 5.8 billion was allocated for TB services, falling short of the required amounts to achieve global targets. Moreover, WHO emphasizes the need for sustained & increased funding to combat TB effectively. Hence, the U.S. government has significantly increased its funding for TB initiatives, from USD 233 million in 2013 to USD 406 million in 2023. Investments in screening and preventive treatment have shown significant health & economic benefits, with a return on investment of up to USD 39 for every dollar spent.

Global Infectious Respiratory Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global infectious respiratory disease diagnostics market report based on technology, pathogen, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Reagents
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • COVID-19
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • Tuberculosis
  • Non-tuberculosis Mycobacterium Testing
  • Bacterial Pneumonia Testing
  • Other Respiratory Disease Testing
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunoassay
  • Molecular Diagnostics
  • Microbiology
  • Rapid/Point-of-Care Diagnostics
  • Other Technologies
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Product
    • 1.2.3. End Use
    • 1.2.4. Application
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Infectious Respiratory Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High Prevalence Of Infectious Respiratory Diseases Globally
      • 3.2.1.2. Technological Advancement In Respiratory Disease Testing
      • 3.2.1.3. Rising R&D Investments In Respiratory Disease Testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Prices Of Diagnostic Products
      • 3.2.2.2. Presence Of Ambiguous Regulatory Framework
  • 3.3. Infectious Respiratory Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Infectious Respiratory Disease Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Infectious Respiratory Disease Diagnostics Market: Product Movement Analysis
  • 4.3. Infectious Respiratory Disease Diagnostics Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 4.5. Instruments
    • 4.5.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Reagents
    • 4.6.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Services
    • 4.7.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Infectious Respiratory Disease Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
  • 5.3. Infectious Respiratory Disease Diagnostics Market by Technology Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 5.5. Immunoassay
    • 5.5.1. Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Microbiology
    • 5.7.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Rapid/Point-of-Care Diagnostics
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Other Technologies
    • 5.9.1. Other Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Infectious Respiratory Disease Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
  • 6.3. Infectious Respiratory Disease Diagnostics Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 6.5. COVID-19
    • 6.5.1. COVID-19 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Influenza
    • 6.6.1. Influenza Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Respiratory Syncytial Virus
    • 6.7.1. Respiratory Syncytial Virus Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Tuberculosis
    • 6.8.1. Tuberculosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Non-tuberculosis Mycobacterium Testing
    • 6.9.1. Non-tuberculosis Mycobacterium Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Bacterial Pneumonia Testing
    • 6.10.1. Bacterial Pneumonia Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Other Respiratory Disease Testing
    • 6.11.1. Other Respiratory Disease Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Infectious Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Infectious Respiratory Disease Diagnostics Market: End Use Movement Analysis
  • 7.3. Infectious Respiratory Disease Diagnostics Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
  • 7.5. Hospitals
    • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Diagnostic Laboratories
    • 7.6.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Research Institutes
    • 7.7.1. Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Clinics
    • 7.8.1. Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Infectious Respiratory Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Recent Developments & Impact Analysis by Key Market Participants
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Key Company Profiles
    • 9.4.1. ABBOTT
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. F. Hoffmann - La Roche Ltd
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. BD
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. KONINKLIJKE PHILIPS N.V.
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. BIOMERIEUX SA
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. BIO-RAD LABORATORIES, INC.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. QUIDEL CORPORATION
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. CEPHEID
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. QIAGEN
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. SIEMENS HEALTHCARE GMBH
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Seegene Inc.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. EliTechGroup (Bruker Corporation)
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. CERTEST BIOTEC
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Thermo Fisher Scientific, Inc.
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 6 Global infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 7 North America infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 8 North America infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 9 North America infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 10 North America infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 12 U.S infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 13 U.S infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 14 U.S infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 15 Canada infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 16 Canada infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 17 Canada infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 18 Canada infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Mexico infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 20 Mexico infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 21 Mexico infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 22 Mexico infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 Europe infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 24 Europe infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 25 Europe infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 26 Europe infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 27 UK infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 28 UK infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 29 UK infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 30 UK infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 31 Germany infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 32 Germany infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 33 Germany infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 34 Germany infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 France infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 36 France infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 37 France infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 38 France infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 39 Italy infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 40 Italy infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 41 Italy infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 42 Italy infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 43 Spain infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 44 Spain infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 45 Spain infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 46 Spain infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Denmark infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 48 Denmark infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 49 Denmark infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 50 Denmark infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 51 Sweden infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 52 Sweden infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 53 Sweden infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 54 Sweden infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 55 Norway infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 56 Norway infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 57 Norway infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 58 Norway infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 63 Japan infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Japan infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Japan infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 66 Japan infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 67 China infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 68 China infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 69 China infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 70 China infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 71 India infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 72 India infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 73 India infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 74 India infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 75 Australia infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 76 Australia infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 77 Australia infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 78 Australia infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 South Korea infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 80 South Korea infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 81 South Korea infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 82 South Korea infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 84 Thailand infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 85 Thailand infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 86 Thailand infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 Latin America infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 88 Latin America infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 89 Latin America infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 90 Latin America infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Brazil infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 92 Brazil infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 93 Brazil infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 94 Brazil infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 95 Argentina infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 96 Argentina infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 97 Argentina infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 98 Argentina infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 99 Middle East & Africa infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 100 Middle East & Africa infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 101 Middle East & Africa infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 102 Middle East & Africa infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 103 South Africa infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 104 South Africa infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 105 South Africa infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 106 South Africa infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 111 UAE infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 112 UAE infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 113 UAE infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 114 UAE infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)
  • Table 115 Kuwait infectious respiratory disease diagnostics market, by Product, 2021 - 2033 (USD Million)
  • Table 116 Kuwait infectious respiratory disease diagnostics market, by Application, 2021 - 2033 (USD Million)
  • Table 117 Kuwait infectious respiratory disease diagnostics market, by Technology, 2021 - 2033 (USD Million)
  • Table 118 Kuwait infectious respiratory disease diagnostics market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Infectious respiratory disease diagnostics market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Infectious respiratory disease diagnostics market, Product outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 12 Infectious respiratory disease diagnostics market, Technology outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 13 Infectious respiratory disease diagnostics market, Application outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 14 Infectious respiratory disease diagnostics market, End Use outlook key takeaways (USD Million), 2025 & 2033
  • Fig. 15 Instruments market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Reagents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Services market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Immunoassay market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Molecular Diagnostics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Microbiology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Rapid/Point-of-Care Diagnostics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Other Technologies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 COVID-19 market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Influenza market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Respiratory Syncytial Virus market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Tuberculosis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Non-tuberculosis Mycobacterium Testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Bacterial Pneumonia Testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Other Respiratory Disease Testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Diagnostic Laboratories market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Other End Users market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 North America infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 U S infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Canada infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Europe infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 UK infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Germany infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 France infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Spain infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Italy infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Norway infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Denmark infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Sweden infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Asia Pacific infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 China infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Japan infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 India infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 South Korea infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Australia infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Thailand infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Argentina infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Middle East and Africa infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 South Africa infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Saudi Arabia infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 UAE infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Kuwait infectious respiratory disease diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 List of key emerging company's/Allergen disruptors/innovators